Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1995
08/24/1995CA2183253A1 Rna editing enzyme and methods of use thereof
08/24/1995CA2183157A1 Immunosuppressive compounds and method of preparing same
08/24/1995CA2181827A1 Cyclic heptapeptide anti-inflammatory agent
08/24/1995CA2181367A1 Novel opioid peptides for the treatment of pain and use thereof
08/24/1995CA2160251A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis
08/23/1995EP0668358A1 Antibiotic WAP-8294A, method for preparing the same and antibacterial composition
08/23/1995EP0668357A1 Vector for integration site independent gene expression in mammalian host cells
08/23/1995EP0668354A1 Cysteine added variants of G-CSF and chemical modifications thereof
08/23/1995EP0668353A1 Cysteine added variants of EPO and chemical modifications thereof
08/23/1995EP0668352A1 Protein having TPO activity
08/23/1995EP0668351A1 Erythropoietin isoforms
08/23/1995EP0668349A2 Muteins of pancreatic ribonuclease and uses thereof
08/23/1995EP0668291A2 Mammalian augmenter of liver regenerating and variants thereof
08/23/1995EP0668290A1 Physiologically active substance well capable of permeating biomembrane
08/23/1995EP0668278A1 Adhesion receptor antagonists
08/23/1995EP0668077A1 Compositions containing G-CSF and TNF binding protein
08/23/1995EP0667959A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE $g(b)-AMYLOID PEPTIDE
08/23/1995EP0667916A1 Crf binding protein
08/23/1995EP0667908A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases
08/23/1995EP0667904A1 Suppressor and progenitor cells
08/23/1995EP0667903A1 Recombinant human erythropoietin with altered biological activity
08/23/1995EP0667902A1 Cdr grafted humanised chimeric t-cell antibodies
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667899A1 Mutated growth factor receptor as medicament and its use for treating cancer
08/23/1995EP0667898A1 Tau/neurofilament protein kinases pk40 and pk36
08/23/1995EP0667872A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6
08/23/1995EP0667871A1 Biologically active amphiphilic peptide compositions and uses therefor
08/23/1995EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b)
08/23/1995EP0667859A1 Molecule labelling using 2-hydraninopyridine derivatives
08/23/1995EP0667854A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
08/23/1995EP0667792A1 Specific tolerance in transplantation
08/23/1995EP0667790A1 Regulation of cellular invasiveness
08/23/1995EP0667789A1 Restoration of immunocompetency to t helper cells in hiv infected patients
08/23/1995EP0667785A1 Method of treating non-streptococcal bacterial infections
08/23/1995EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/23/1995EP0667783A1 Compositions and methods for preventing adhesion formation
08/23/1995EP0667782A1 Reconstituted platelet membrane vesicles
08/23/1995EP0667781A1 Peptide diagnostics and therapeutics for spondyloarthropathies
08/23/1995EP0667780A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents
08/23/1995EP0667778A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene
08/23/1995EP0667771A1 Antitumour compositions containing taxane derivatives
08/23/1995EP0652731A4 Composition of low type iii content human placental collagen.
08/23/1995EP0574398B1 Utilization of immunoglobulines administered locally in the treatment of epithelial infections
08/23/1995EP0522010B1 Bcrf1 antagonists for treating epstein-barr virus infections
08/23/1995EP0494929B1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use
08/23/1995EP0371036B1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
08/23/1995EP0110955B1 Brain-specific drug delivery
08/23/1995CN1107159A Linear adhesion inhibitors
08/23/1995CN1107041A Transmucosal delivery of macromolecular drugs
08/23/1995CN1029541C Nutritional composition and process for its production
08/22/1995US5444158 Merosin, nucleic acids encoding, fragments and uses thereof
08/22/1995US5444157 Stimulates growth of chondrocytes and/or inhibits growth of tumors
08/22/1995US5444156 Monoclonal antibodies to human plasma prekallikrein
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5444152 Endothelin antagonistic peptide derivatives
08/22/1995US5444151 Platelet derived growth factor antagonists
08/22/1995US5444064 Method of treating gastrointestinal malignancies
08/22/1995US5444063 95% free of corresponding beta-L enantiomer; oral or parenteral administeration
08/22/1995US5444049 Peptide compounds derived from boronic acid
08/22/1995US5444048 Antiinflammatory agents, analgesics
08/22/1995US5444047 Administering to reduce atrophy in striated skeletal muscles
08/22/1995US5444046 Polypeptides
08/22/1995US5444045 Method of administering IGF-1, IGF-2, and analogs thereof to birds
08/22/1995US5444044 Synthetic polypeptides as inhibitors of HIV-1
08/22/1995US5444043 Cyclic depsipeptide non-steroidal antiinflammatory agent
08/22/1995US5444042 Method of treatment of neurodegeneration with calpain inhibitors
08/22/1995US5444041 Convertible microemulsion formulations
08/22/1995US5443976 Making antivenoms of rattlesnakes by attaching two whole venoms having antibody binding capacity to insoluble aldehyde activated agarose substrate by covelentyl bonding
08/22/1995US5443968 Fed batch culture method for protein secreting cells
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443966 Expression of tetanus toxin fragment C
08/22/1995US5443965 Peptide antigens used in diagnosis
08/22/1995US5443962 Methods of identifying inhibitors of cdc25 phosphatase
08/22/1995US5443953 Genetic engineering; diagnosis, therapy
08/22/1995US5443848 Administering certain ratios of sodium chloride and sodium acetate; treating hemorrhagic shock
08/22/1995US5443829 For enhancing delivery of drugs across mucous membranes of animals
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/22/1995US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis
08/22/1995US5443816 Peptide-metal ion pharmaceutical preparation and method
08/22/1995US5443815 Technetium-99m labeled peptides for imaging
08/22/1995US5443531 Delivery system for biologically active growth or morphogenetic factors and to a method for preparing such a delivery system
08/22/1995CA1336774C Perhydrothiazepine and perhydroazepine derivatives their preparation and their therapeutic use
08/22/1995CA1336763C Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement
08/20/1995CA2142741A1 Adhesion receptor antagonists
08/17/1995WO1995021931A1 Nucleic acid-containing composition, its preparation and use
08/17/1995WO1995021927A2 Targeting gene therapy
08/17/1995WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995WO1995021920A1 Hematopoietic protein and materials and methods for making it
08/17/1995WO1995021919A2 Protein having tpo activity
08/17/1995WO1995021918A1 Rat osteosarcoma cell lines
08/17/1995WO1995021917A1 Mammalian cell cycle protein
08/17/1995WO1995021916A2 pp32: A NEWLY IDENTIFIED CD45-ASSOCIATED PROTEIN
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021867A1 Granulocyte colony-stimulating factor receptor (g-csf-r) interactive molecules
08/17/1995WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021864A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
08/17/1995WO1995021863A1 Prostaglandin i2 receptor
08/17/1995WO1995021862A1 Isolated antigenic oncogene peptide fragments and uses
1 ... 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 ... 3163